Evaluation of a Pharmacist-Managed Amiodarone Monitoring Program

BACKGROUND: Because of the potential for serious adverse effects, patients treated with amiodarone must be carefully screened and routinely monitored for potential liver, thyroid, and pulmonary toxicity. However, laboratory and pulmonary monitoring rates have been found to be substantially lower tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Spence, Michele M., Polzin, Jennifer K., Weisberger, Calvin L., Martin, John P., Rho, Jay P., Willick, Giselle H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437408/
https://www.ncbi.nlm.nih.gov/pubmed/21870892
http://dx.doi.org/10.18553/jmcp.2011.17.7.513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437408/
https://www.ncbi.nlm.nih.gov/pubmed/21870892
http://dx.doi.org/10.18553/jmcp.2011.17.7.513

Ejemplares similares